We’re excited to share the inaugural episode of the Sheridan Spotlight, a new series where members of our firm sit down with leaders from across the healthcare ecosystem to explore the trends, challenges, and innovations shaping the industry. In our first episode, Sheridan’s own Sean Dempsey is joined by Dr. Peter Fleischut, Executive Vice President, […]
AUBURN, NY — October 15, 2026 — Currier Plastics, a contract development and manufacturing organization (CDMO) serving the medical device, pharmaceutical, diagnostic and consumer markets, today announced its rebranding to Alentra.
CHICAGO, IL – October 7, 2026 – (“Sheridan” or “SCP”) today announced the successful closing of Sheridan Capital Partners Fund IV (“Fund IV”) at its hard cap with $1.1 billion of total institutional capital commitments.
Sheridan Capital Partners discusses its acquisition of Carolina Components Group and the trends shaping biopharma M&A.
CHICAGO, IL – September 17, 2026 – Sheridan Capital Partners (“Sheridan” or “the Firm”) today announced the completion of its investment in PtEverywhere (“PtE” or “the Company”), a practice management and integrated payments software platform serving outpatient physical therapy and related rehabilitation providers. Terms of the private transaction were not disclosed.
TOMS RIVER, NJ – August 25, 2026 – Cadara™, formerly National Care Systems, today announced the appointment of Marina Aslanyan as Chief Executive Officer. She joins Cadara as the company continues expanding its technology platform and executing its long-term strategic vision.
CHICAGO, IL – August 7, 2026 – Sheridan Capital Partners (“Sheridan”) today announced that its portfolio company, Currier Plastics (“Currier”), has completed the strategic acquisition of Sage Product Development (“Sage”), an engineering, design and development provider that helps its medical device customers take their products from concept to commercialization.
CHICAGO, IL – August 4, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Carolina Components Group (“CCG” or the “Company”), a provider of custom-engineered bioprocessing assemblies and components used in the manufacturing of biopharmaceuticals.